Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
Northwestern University
Northwestern University
University of Texas Southwestern Medical Center
University of Miami
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center